Premature Discontinuation of Direct Acting Antiviral (DAA) Therapy in Patients with Chronic Hepatitis C Virus (HCV) in Real World Clinical Practice

Hanifi Jasmine M.; Lin Ming V.

首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Premature Discontinuation of Direct Acting Antiviral (DAA) Therapy in Patients with Chronic Hepatitis C Virus (HCV) in Real World Clinical Practice

【24h】

Premature Discontinuation of Direct Acting Antiviral (DAA) Therapy in Patients with Chronic Hepatitis C Virus (HCV) in Real World Clinical Practice

机译：现实世界临床实践中慢性丙型肝炎病毒（HCV）患者直接代理抗病毒（DAA）治疗的过早停止

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Hepatology: Official Journal of the American Association for the Study of Liver Diseases》 |2016年第s1期|共1页
作者
Hanifi Jasmine M.; Lin Ming V.;
展开▼
作者单位

Brigham &

Womens Hosp Internal Med 75 Francis St Boston MA 02115 USA;

Brigham &

Womens Hosp Div Gastroenterol Hepatol &

Endoscopy 75 Francis St Boston MA 02115 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类消化系及腹部疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Premature Discontinuation of Direct Acting Antiviral (DAA) Therapy in Patients with Chronic Hepatitis C Virus (HCV) in Real World Clinical Practice [J] . Hanifi Jasmine M., Lin Ming V. Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2016,第S1期

机译：现实世界临床实践中慢性丙型肝炎病毒（HCV）患者直接代理抗病毒（DAA）治疗的过早停止
2. Changes in the use of direct acting antiviral(s) (DAA) in the treatment of chronic hepatitis C (CHC) patients in clinical practice. HERACLIS: a Hellenic multicenter real-life cohort clinical study [J] . Papatheodoridis George V., Koskinas John, Goulis Ioannis, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：直接作用抗病毒（DAA）在临床实践中治疗慢性丙型肝炎患者的使用变化。 Heraclis：Hellenic MultiCenter现实生活队列临床研究
3. Risk and outcome of hepatitis B virus (HBV) reactivation during chronic hepatitis C treatment with direct-acting antivirals (DAAs) in patients with HCV-related advanced fibrosis: a single-center experience [J] . DAmbrosio Roberta, Degasperi Elisabetta, Aghemo Alessio, Hepatology: Official Journal of the American Association for the Study of Liver Diseases . 2017,第Suppla1期

机译：乙型肝炎病毒（HBV）慢性丙型肝炎病毒（HBV）重新激活的风险和结果用HCV相关的先进纤维化患者直接作用抗病毒（DAAs）：单中心经验
4. Hepatic Iron Staining in Chronic Hepatitis C Patients With Low Hcv Rna Levels As A Predictive Marker For interferon therapy [C] . Tatsuya Ide, Fuyuhiko Akiyoshi, Michio Sata, Yamaguchi Symposium on Liver Disease . 2003

机译：慢性丙型肝炎患者肝脏染色低HCV RNA水平作为干扰素治疗的预测标志物
5. The Distribution of Change over Time in Metabolic, Inflammatory, and Immune Parameters in HCV-monoinfected and HIV/HCV-coinfected Patients Cured of Hepatitis C Virus by Direct-Acting Antiviral Therapy [D] . Emmanuel, Benjamin. 2018

机译：通过直接作用抗病毒治疗，在HCV-单染料和HCV / HCV / HCV-焦收的患者中的代谢，炎症和免疫参数随时间随时间的分布，通过直接作用抗病毒治疗治愈丙型肝炎病毒
6. All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practice: Madrid coinfection registry findings [O] . Juan Berenguer, Ángela Gil‐Martin, Inmaculada Jarrin, -1

机译：在现实生活中针对人类免疫缺陷病毒/ HCV合并感染的受试者进行的针对丙型肝炎病毒（HCV）的全口径直接作用抗病毒治疗：马德里共同感染登记册调查结果
7. Rates of sustained virological response 12 weeks after the scheduled end of direct-acting antiviral (DAA)-based hepatitis C virus (HCV) therapy from the National German HCV registry: does HIV coinfection impair the response to DAA combination therapy? [O] . J Bischoff, S Mauss, C Cordes, 2018

机译：直接作用抗病毒（DAA）的丙型肝炎病毒（HCV）治疗的预定结束后12周持续持续的病毒学响应率：HIV繁殖会损害对DAA组合治疗的反应吗？

Premature Discontinuation of Direct Acting Antiviral (DAA) Therapy in Patients with Chronic Hepatitis C Virus (HCV) in Real World Clinical Practice

著录项

相似文献

相关主题

期刊订阅